GeoVax Labs Stock Continues To Surge: What's Going On?

GeoVax Labs Inc GOVX shares continue to rally Monday adding to gains of more than 225% over the past week. Here’s a look at what you need to know.

What To Know: GeoVax, and several healthcare stocks associated with mpox, began moving higher last week after the World Health Organization declared a public health emergency in response to an mpox outbreak in Africa.

The WHO determined last week that the recent surge of mpox, previously known as monkeypox, across a growing number of countries in Africa constituted a public health emergency of international concern under International Health Regulations.

"The emergence of a new clade of mpox, its rapid spread in eastern DRC, and the reporting of cases in several neighbouring countries are very worrying. On top of outbreaks of other mpox clades in DRC and other countries in Africa, it’s clear that a coordinated international response is needed to stop these outbreaks and save lives," the WHO Director-General said.

Geovax Labs is a clinical-stage biotechnology company engaged in developing immunotherapies and vaccines against cancers and infectious diseases. The company previously published information in peer-reviewed journals suggesting its vaccines help prevent mpox.

EF Hutton analyst Jason Kolbert maintained Geovax with a Buy rating and price target of $18 Monday morning.

Geovax is scheduled to present at the next Emerging Growth Conference, taking place on Wednesday and Thursday. The live online event will give existing shareholders and the investment community the opportunity to interact with the company’s chairman and CEO David Dodd.

See Also: Stock Of The Day: Bull Trap Snares SIGA Technologies On Heels Of Mpox Study

How To Buy GOVX Stock

By now you're likely curious about how to participate in the market for Geovax – be it to purchase shares, or even attempt to bet against the company.

Buying shares is typically done through a brokerage account. You can find a list of possible trading platforms here. Many will allow you to buy ‘fractional shares,' which allows you to own portions of stock without buying an entire share. In the case of Geovax, which is trading at $10.68 as of publishing time, $100 would buy you 9.36 shares of stock.

If you're looking to bet against a company, the process is more complex. You'll need access to an options trading platform, or a broker who will allow you to ‘go short' a share of stock by lending you the shares to sell. The process of shorting a stock can be found at this resource. Otherwise, if your broker allows you to trade options, you can either buy a put option, or sell a call option at a strike price above where shares are currently trading – either way it allows you to profit off of the share price decline.

GOVX Price Action: GeoVax shares were up 51.3% at $10.68 at the time of publication Monday, according to Benzinga Pro.

Photo: Shutterstock.